Article
Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations.
Leukemia & lymphoma - 1 Jan 2015
Hirsch Pierre, Qassa Ghazi, Marzac Christophe, Tang Ruoping, Perrot Jean-Yves, Isnard Françoise, Mohty Mohamad, Marie Jean Pierre, Legrand Ollivier
Abstract excerpt
The benefit associated with chemotherapy in older patients with acute myeloid leukemia (AML) is debated. The prognostic impact of molecular mutations in these patients is unknown. We identified 79 patients with AML aged 75 years or over. Forty-two received chemotherapy and 37 supportive care only. In intensively treated patients, overall survival was longer (p < 0.001). Achieving complete remission was associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
